antithrombotic agents	treat	thrombosis
antithrombotic agents	prevent	embolism
antithrombotic agents	reduce	stroke risk
antithrombotic agents	lower	myocardial infarction
antithrombotic agents	include	anticoagulants
antithrombotic agents	include	antiplatelets
antithrombotic agents	include	fibrinolytics
antithrombotic agents	include	thrombolytics
anticoagulants	inhibit	coagulation cascade
anticoagulants	include	warfarin
anticoagulants	include	heparin
anticoagulants	include	DOACs
DOACs	include	apixaban
DOACs	include	rivaroxaban
DOACs	include	dabigatran
DOACs	include	edoxaban
antiplatelets	inhibit	platelet aggregation
antiplatelets	include	aspirin
antiplatelets	include	clopidogrel
antiplatelets	include	ticagrelor
antiplatelets	include	prasugrel
fibrinolytics	dissolve	fibrin clot
fibrinolytics	include	alteplase
fibrinolytics	include	reteplase
fibrinolytics	include	tenecteplase
antithrombotic agents	used in	atrial fibrillation
antithrombotic agents	used in	venous thromboembolism
antithrombotic agents	used in	coronary artery disease
antithrombotic agents	used in	peripheral artery disease
antithrombotic agents	used in	mechanical heart valve
antithrombotic agents	contraindicated in	active bleeding
antithrombotic agents	contraindicated in	severe thrombocytopenia
antithrombotic agents	contraindicated in	recent stroke
antithrombotic agents	contraindicated in	pregnancy
antithrombotic agents	monitored by	INR
antithrombotic agents	monitored by	aPTT
antithrombotic agents	monitored by	anti‑Xa
antithrombotic agents	monitored by	renal function
antithrombotic agents	interact with	NSAIDs
antithrombotic agents	interact with	SSRIs
antithrombotic agents	interact with	CYP3A4 inhibitors
antithrombotic agents	interact with	CYP2C9 inhibitors
antithrombotic agents	cause	bleeding risk
antithrombotic agents	cause	bruising
antithrombotic agents	cause	anemia
antithrombotic agents	cause	thrombocytopenia
antithrombotic agents	cause	GI ulcer
antithrombotic agents	cause	intracranial hemorrhage
antithrombotic agents	benefit	mortality reduction
antithrombotic agents	benefit	quality of life
antithrombotic agents	benefit	rehospitalization reduction
antithrombotic agents	benefit	readmission prediction
antithrombotic agents	benefit	cost‑effectiveness
antithrombotic agents	dosage	weight‑based
antithrombotic agents	dosage	renal‑adjusted
antithrombotic agents	dosage	age‑adjusted
antithrombotic agents	dosage	drug‑drug interaction
antithrombotic agents	dosage	therapeutic window
antithrombotic agents	dosage	loading dose
antithrombotic agents	dosage	maintenance dose
antithrombotic agents	administration	oral
antithrombotic agents	administration	intravenous
antithrombotic agents	administration	subcutaneous
antithrombotic agents	administration	transdermal
antithrombotic agents	administration	implantable
antithrombotic agents	monitoring	platelet count
antithrombotic agents	monitoring	coagulation profile
antithrombotic agents	monitoring	renal function
antithrombotic agents	monitoring	liver function
antithrombotic agents	monitoring	drug levels
antithrombotic agents	monitoring	adverse events
antithrombotic agents	monitoring	patient adherence
antithrombotic agents	monitoring	drug interactions
antithrombotic agents	monitoring	genetic polymorphisms
antithrombotic agents	monitoring	pharmacogenomics
antithrombotic agents	monitoring	therapeutic drug monitoring
antithrombotic agents	monitoring	risk scores
antithrombotic agents	monitoring	HAS‑BLED score
antithrombotic agents	monitoring	CHA₂DS₂‑VASc score
antithrombotic agents	monitoring	VTE risk assessment
antithrombotic agents	monitoring	bleeding risk assessment
antithrombotic agents	monitoring	patient education
antithrombotic agents	monitoring	lifestyle modification
antithrombotic agents	monitoring	diet
antithrombotic agents	monitoring	alcohol consumption
antithrombotic agents	monitoring	smoking cessation
antithrombotic agents	monitoring	exercise
antithrombotic agents	monitoring	weight management
antithrombotic agents	monitoring	medication reconciliation
antithrombotic agents	monitoring	electronic health record alerts
antithrombotic agents	monitoring	clinical decision support
antithrombotic agents	monitoring	predictive analytics
antithrombotic agents	monitoring	machine learning models
antithrombotic agents	monitoring	risk stratification
antithrombotic agents	monitoring	outcome prediction
antithrombotic agents	monitoring	readmission risk
antithrombotic agents	monitoring	mortality risk
antithrombotic agents	monitoring	adverse event prediction
antithrombotic agents	monitoring	drug efficacy
antithrombotic agents	monitoring	patient satisfaction
